復星醫藥(02196.HK)控股股東及一致行動人累計增持2593萬股H股
格隆匯5月24日丨復星醫藥(02196.HK)公佈,2021年5月21日,公司接公司控股股東復星高科技及其控股股東FosunInternational Limited關於增持公司股份進展的通知,2020年12月1日至2021年5月21日期間,復星高科技及其控股股東FosunInternational Limited通過上海證券交易所港股通交易系統和香港聯合交易所有限公司交易系統累計增持公司2593萬股H股股份,累計增持金額摺合人民幣約86,934萬元,累計增持股份比例佔截至2020年12月1日公司已發行股份總數的約1.01%。
截至2021年5月21日收市,復星高科技及其控股股東FosunInternational Limited合計持有公司1,013,628,790股股份(其中:938,095,290股A股、75,533,500股H股),佔截至2021年5月21日公司已發行股份總數的約39.55%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.